Malaria vaccine pilot test raises hopes of taming killer disease

Mosquirix, the brand name for RTS, S vaccine, triggers the immune system to defend itself against the first stages of the disease. GRAPHIC | NMG

Kenya will in weeks start a large-scale pilot test for a malaria vaccine in efforts to reduce the burden of the disease.

Malawi, which has started its pilot, will also be joined by Ghana, the three States being first in Africa to test the waters with the mosquirix vaccine, which will be administered as part of routine childhood immunisation.

PAYE Tax Calculator

Note: The results are not exact but very close to the actual.